13F Data
13F filer · CIK 1978599

Allostery Investments LP

Stamford, CT · filing since Q4 2024 · last filing Nov 14, 2025
Reported value
$0
$-7.9M vs prior
Positions
1
New / sold out
1 / 20
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $7.9M
Top-10 weight
–

Biggest buys vs Q2 2025

ChangeSecurityShares changeChange %Est. trade value
New00––

Biggest sells vs Q2 2025

ChangeSecurityShares changeChange %Est. trade value
Sold outABIVAX SA-167,350-100.0%$-1.3M
Sold outAKERO THERAPEUTICS INC-22,500-100.0%$-1.2M
Sold outAMYLYX PHARMACEUTICALS INC-120,119-100.0%$-770.0K
Sold outCENTESSA PHARMACEUTICALS PLC-52,500-100.0%$-689.9K
Sold outEVOLUS INC-60,000-100.0%$-552.6K
Sold outREZOLUTE INC-119,294-100.0%$-532.1K
Sold outMERUS N V-9,000-100.0%$-473.4K
Sold outKALVISTA PHARMACEUTICALS INC-40,000-100.0%$-452.2K
Sold outFULCRUM THERAPEUTICS INC-40,353-100.0%$-277.6K
Sold outAPOGEE THERAPEUTICS INC-6,000-100.0%$-260.6K
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2024: $95.7MQ1 2025: $69.3MQ2 2025: $7.9MQ3 2025: $0
Q4 2024Q3 2025

Holdings · Q3 2025

#SecuritySharesValueWeight
1000$0–